Paraquat Lawsuits in 2026: Parkinson's Claims Against the Makers
Paraquat is a highly restricted herbicide used on American farms since the 1960s. Thousands of farmers and applicators who mixed or sprayed it have since been diagnosed with Parkinson's disease, alleging Syngenta and Chevron failed to warn of the neurological risk. More than 6,600 federal cases are consolidated in MDL 3004 in Illinois, with a 2025 settlement being administered while state-court trials move forward.
Key Facts
- As of October 1, 2026, 6,602 actions were pending in MDL No. 3004 in the Southern District of Illinois, 8,495 have been filed in total since it began (per schmidtandclark.com).
- The defendants are Syngenta Crop Protection LLC, Syngenta AG, and Chevron U.S.A. Inc.; the MDL is before Chief Judge Nancy J. Rosenstengel (per schmidtandclark.com).
- A Master Settlement Agreement was executed on September 3, 2025, but its payment terms are not public; hundreds of plaintiffs rejected offers and entered limited discovery in June 2026 (per aboutlawsuits.com).
- Paraquat is banned in more than 70 countries, including the European Union and China, but remains legal in the U.S. for licensed applicators; U.S. usage has risen nearly 200 percent since 2009 (per sokolovelaw.com; callfob.com).
- Going into October 2026, another 2,080 plaintiffs had cases in the Philadelphia Court of Common Pleas mass tort, with the first bellwether trial set for January 2026 (per motleyrice.com).
What Paraquat Is and How Exposure Happens
Paraquat dichloride is one of the most widely used herbicides in the United States, introduced in the 1960s and valued because it becomes inactive on contact with soil, which suits no-till crop systems. It is also acutely toxic: sold as Gramoxone, Firestorm, Helmquat, and Parazone, only licensed applicators may use it. Here, exposure means years of mixing, loading, and spraying the chemical, breathing spray drift, or absorbing it through the skin during farm or landscaping work. Plaintiffs cite epidemiological research, including the Agricultural Health Study framework, linking repeated exposure to increased Parkinson's disease risk, a progressive neurological disorder that impairs movement. The defendants deny liability, and the court has made no finding that paraquat causes Parkinson's disease.
What the Lawsuits Allege
The core allegation is failure to warn: plaintiffs say Syngenta and Chevron knew or should have known about evidence linking paraquat to neurological damage, yet sold it without adequate warnings about the Parkinson's risk. The claims sound in product liability and negligence, alleging the companies endangered farmers and applicators without telling them. The litigation stresses the contrast between paraquat's ban in dozens of countries and its continued sale in the United States under restricted-use rules. A case requires documented exposure, a confirmed Parkinson's diagnosis, and expert testimony connecting the two. Failure-to-warn claims are the backbone of many toxic-exposure cases, and our guide to duodenoscope infection claims shows how courts handle products alleged to carry undisclosed risks.
Where the Litigation Stands in 2026
All federal cases are consolidated in MDL No. 3004 before Chief Judge Nancy J. Rosenstengel in the Southern District of Illinois. An MDL, short for multidistrict litigation, gathers similar federal lawsuits before one judge for coordinated pretrial proceedings. In September 2025, the parties executed a Master Settlement Agreement covering certain individual claims, but its payment terms are not public. Hundreds of plaintiffs rejected the tentative settlement offers, and in June 2026 the court ordered those who declined into limited discovery; if the settlement collapses, the judge may revive federal bellwether trials. Parallel state-court litigation is advancing in Philadelphia, with the first bellwether trial scheduled for January 2026, after the U.S. Supreme Court declined on October 6, 2025 to review a jurisdiction challenge in Syngenta v. Nemeth. Mass-tort resolutions often follow this pattern of partial settlement alongside contested opt-outs, as seen in the Juul vaping settlement. Video explainers such as Problem Solved on YouTube walk through how this kind of claim is built.
Who Benefits From This — and Who Does Not
The people who benefit most are farmers, pesticide applicators, landscapers, and agricultural workers diagnosed with Parkinson's disease after years of mixing, loading, or spraying paraquat, especially those who can document their work history and products used. Families caring for a person whose Parkinson's followed documented exposure benefit as well, since the disease creates large medical and caregiving costs. Compensation varies widely by case, and most settlements are confidential. Workers harmed by other products sold without adequate warnings face the same analysis, and our Tasigna atherosclerosis lawsuit report shows how undisclosed-risk claims are evaluated.
There are also people for whom a claim is not the right path. A Parkinson's diagnosis without any paraquat exposure does not support this litigation, and casual contact, such as driving past a sprayed field once, rarely meets the exposure the cases allege. People whose symptoms began before any exposure, or who cannot document when they handled the herbicide, face difficult causation battles. State filing deadlines can also be short, so delay can cost a valid claim its chance.
This article provides general information only and is not legal advice. Paraquat claims depend on your exposure history, diagnosis, and your state's filing deadlines; consult a qualified attorney about your situation.
Frequently Asked Questions
Who benefits most from a paraquat lawsuit?
Farmers, applicators, landscapers, and agricultural workers diagnosed with Parkinson's after documented, repeated exposure to paraquat products such as Gramoxone benefit most. The strongest cases combine years of mixing, loading, or spraying with a clear diagnosis and work records.
Who does not qualify for a paraquat claim?
People diagnosed with Parkinson's who never handled paraquat do not qualify, nor do those with only brief or incidental contact. People whose symptoms began before any exposure, or who cannot document when they handled the herbicide, face difficult causation problems.
How do I start a paraquat Parkinson's claim?
First, gather work records showing you mixed, loaded, or applied paraquat, including product names and years of use. Second, collect your Parkinson's diagnosis and treatment records. Third, write down the timeline of your exposure and diagnosis. Fourth, consult a toxic-tort attorney promptly, since state filing deadlines can be short.
Has the court found that paraquat causes Parkinson's disease?
No. The court has made no finding that paraquat causes Parkinson's disease. Plaintiffs rely on studies suggesting an association between repeated exposure and increased risk, while the defendants deny liability. Causation remains a central disputed issue in the litigation.
What is the status of the paraquat settlement?
A Master Settlement Agreement was executed on September 3, 2025, but its payment terms are not public. Hundreds of plaintiffs rejected their settlement offers and were ordered into limited discovery in June 2026, so the litigation continues while the settlement is administered.